Variables (n = 68) | Cut off level | Number of patients | HR | 95%CI | p |
---|---|---|---|---|---|
Sex male/female | Â | 56/12 | 0.671 | 0.318- 1.413 | 0.293 |
Age < 70 years/ ≥ 70 years/ |  | 52/16 | 1.211 | 0.592- 2.474 | 0.600 |
Performance status 0/1 | Â | 57/11 | 1.503 | 0.665- 3.394 | 0.327 |
Histological differentiation intestinal /diffuse | Â | 41/27 | 1.859 | 0.927- 3.727 | 0.081 |
Haematogenous +/- | Â | 29/39 | 1.742 | 0.938- 3.230 | 0.078 |
Lymphogenous +/- | Â | 47/21 | 0.568 | 0.302- 1.068 | 0.079 |
Yoshida classification category 1/2 |  | 23/45 | 2.595 | 1.261–5.341 | 0.011 |
Multiple non-curative factors +/- |  | 39/29 | 1.707 | 0.921–3.164 | 0.089 |
Albumin (g/dl) low/high | 3.8 | 37/31 | 0.447 | 0.233- 0.853 | 0.015 |
CEA (ng/ml) low/high | 5 | 38/30 | 0.719 | 0.384- 1.343 | 0.301 |
CA19-9 (U/ml) low/high | 37 | 43/25 | 1.392 | 0.745- 2.598 | 0.299 |
NLR low/high | 3.1 | 31/37 | 2.142 | 1.134- 4.047 | 0.018 |
PLR low/high | 189 | 33/35 | 0.092 | 0.914- 3.207 | 0.092 |
LMR low/high | 3.7 | 32/36 | 0.479 | 0.257- 0.892 | 0.020 |
CD4+ lymphocyte /Hpf low/high | 15 | 29/39 | 0.610 | 0.329–1.129 | 0.116 |
CD8+ lymphocyte /Hpf low/high | 34 | 54/14 | 0.324 | 0.126–0.832 | 0.019 |
Foxp3+ lymphocyte /Hpf low/high | 9 | 47/21 | 1.671 | 0.886- 3.150 | 0.112 |
CD68+ macrophage /Hpf low/high | 28 | 36/32 | 1.593 | 0.856- 2.964 | 0.142 |
CD163+ macrophage /Hpf low/high | 35 | 28/40 | 3.459 | 1.725–6.937 | 0.001 |